共查询到20条相似文献，搜索用时 325 毫秒
1.
为评价Rev.1-ΔKan-Vir B12突变株在BALB/c鼠中的免疫保护力,以Rev.1为参照,用Rev.1-ΔKanVir B12接种BALB/c小鼠,免疫45 d后用布鲁氏菌16M强毒株攻毒,15 d后取BALB/c鼠脾脏进行克脾指数测定和病理组织学检测。结果显示:BALB/c鼠免疫攻毒15 d后,Rev.1-ΔKan-Vir B12免疫组和Rev.1免疫组的克脾指数与对照组之间有显著性差异(P0.05),而Rev.1免疫组与Rev.1-ΔKan-Vir B12免疫组之间的克脾指数差异不显著(P0.05)。结果表明,羊布鲁氏菌Rev.1-ΔKan-Vir B12突变株与其亲本Rev.1株的免疫保护性无明显差异,具备作为布鲁氏菌病标记疫苗的潜力。 相似文献
2.
布鲁氏菌VirB8变异株的构建及其感染力和毒力的测定 总被引：1，自引：1，他引：0
作者拟对缺失致病力因子--四型分泌系统中的VirB8基因后布鲁氏菌感染力和毒力的变化进行测定与分析.首先,构建了布鲁氏菌VirB8基因缺失株(△B8B.suis),用缺失株感染巨噬细胞和BALB/c小鼠,再用B.suis强毒攻击BALB/c小鼠并检测脾脏含菌数,观察其在动物体内定居能力、毒力及抗感染保护力.鉴定△B8B.suis为VirB8基因完全缺失株,△B8B.suis感染巨噬细胞6、24和48 h,其CFU分别为49、165和355;△B8B.suis感染BALB/C小鼠的每克脾含菌数为3.6×107(1×108CFU腹腔接种)和5×106(1×109CFU蹊部接种);BALB/c小鼠攻毒试验显示△B8B.suis免疫组每克脾平均含菌数为7.61×102,非免疫对照组为2.98×105.结果表明布鲁氏菌缺失VirB8基囚后,其毒力较亲本株弱,但能在小鼠脾脏定居,为弱毒株;△B8B.suis呈现出作为疫苗的生物学特性,但毒株能否作为疫苗株使用,还需进一步验证. 相似文献
3.
旨在获得具有良好免疫效果的候选抗原,本研究原核表达了副猪格拉瑟菌6个具有潜在保护力的蛋白,对小鼠免疫后进行攻毒,以期筛选获得具有免疫保护效果较好的候选抗原,从而为开发具有交叉保护作用的副猪格拉瑟菌亚单位疫苗奠定基础。63只BALB/c小鼠随机平均分为9组：HPSNAG-1330、CyaY、HPSNAG-0978、HPSNAG-0140、AfuA以及Fe3+ABC-tbp 6个亚单位疫苗组、G.parasuis-5灭活苗组、攻毒对照组和空白组;亚单位疫苗组每种对应蛋白各免疫50μg·只-1,灭活苗组免疫4×109CFU,一免与二免间隔14 d,二免14 d后攻毒,副猪格拉瑟菌Nakasaki菌株攻毒剂量为1.26×109CFU。在二免14 d后检测特异性抗体水平、淋巴细胞增殖和IL-2、IL-6、IL-10、IFN-γ和TNF-α的表达,攻毒后观察小鼠的临床症状并观察肺、脾的组织病理变化。免疫组小鼠均能产生体液免疫反应;淋巴细胞增殖试验显示：除rAfuA外,其它重组蛋白均能刺激灭活苗组中小鼠淋巴细胞显... 相似文献
4.
用不同剂量的口蹄疫灭活疫苗免疫3组雌性BALB／c小鼠，同时设空白对照组，每组8只。免疫后每7d采血一次，用液相阻断ELISA（LPB-ELISA）检测血清抗体水平；第28d用800LD50同源强毒攻击，攻毒后36h，每组随机选取3只BALB／c小鼠，采全血，分别用每只BALg／c小鼠全血注射12只乳鼠，每组共注射36只乳鼠，以乳鼠试验判定BALB／c小鼠的病毒血症和攻毒保护情况。结果表明，免疫组BALB／c小鼠均可产生特异性抗体，保护率分别为75．0％、63．9％、36．1％；对照组小鼠血清抗体为阴性。提示，BALB／c小鼠可以用来评价口蹄疫灭活疫苗的免疫效力。 相似文献
5.
三种布鲁氏菌病疫苗株的毒力比较 总被引：4，自引：2，他引：2
为系统比较我国现有布鲁氏菌病疫苗株A19、M5和S2的毒力,分别用上述3种疫苗株以1×105CFU/只免疫Balb/c小鼠,免疫后每隔2周采集小鼠脾脏,分离细菌,测定各疫苗株在小鼠脾脏中的存留时间。结果 A19、M5、S2在小鼠体内存活时间依次为14周、大于16周、6周。将以上3种疫苗株分别以1×109CFU/只免疫Hartley豚鼠,15日后测定豚鼠脾脏含菌量,结果 A19、M5、S2免疫后每克脾脏含菌量分别为2.8×104CFU、大于6.7×105CFU、3.8×103CFU。研究结果表明,我国目前使用的布鲁氏菌疫苗中,S2毒力最弱,A19其次,M5最强。 相似文献
6.
为开发一种安全有效的布鲁氏菌疫苗,解决现有A19、S2和M5等弱毒疫苗存在较强毒力可感染人,且无法通过血清学方法将其免疫抗体与野毒感染抗体进行鉴别区分的问题,本试验将含有噬菌体PhiX174裂解酶基因E的质粒转化至A19疫苗株,构建菌影疫苗(A19-BG)菌株,并检验其遗传稳定性及对小鼠的安全性、免疫效果和保护效果。结果显示,构建成功的A19-BG菌株传代20代仍稳定,热诱导48 h后可完全灭活,菌体穿孔明显。A19-BG疫苗免疫小鼠7 d后免疫部位无不良反应,14 d后脾脏无可见病理变化,与空白对照组相比脾脏重量无显著差异(P>0.05)。一免和二免后14 d,免疫小鼠的布鲁氏菌抗体、白细胞介素4(IL-4)和γ干扰素(IFN-γ)水平持续升高,产生了良好的体液和细胞免疫反应。布鲁氏菌2308强毒株攻毒免疫小鼠,免疫保护率可达87.5%,保护效果良好。结果表明,构建的A19-BG疫苗具有良好的稳定性、安全性、免疫效果和保护效果,有望成为一种极具潜力的布鲁氏菌新型疫苗。 相似文献
7.
无乳链球菌是导致奶牛乳腺炎的重要病原菌,本研究评价了SIP(surface immunogenic protein)亚单位疫苗对小鼠无乳链球菌乳腺炎的免疫保护效果。制备无乳链球菌SIP亚单位疫苗和灭活疫苗,对小鼠进行免疫,并设PBS阴性对照。免疫前后采血测定IgG及IgG亚类的抗体滴度。免疫小鼠分娩后第4天,进行无乳链球菌乳腺攻毒试验。24h后扑杀攻毒鼠,进行乳腺内CFU的测定,制作并观察乳腺组织病理切片。结果显示,SIP亚单位疫苗免疫组IgG及IgG亚类抗体滴度显著高于灭活疫苗组(P0.01)。免疫哺乳小鼠乳腺攻毒后,SIP亚单位疫苗免疫组小鼠乳腺CFU显著低于灭活疫苗组及对照组(P0.001)。乳腺病理切片显示SIP亚单位疫苗组乳腺组织结构较对照组完整,且中性粒细胞浸润程度最小。本研究表明,无乳链球菌SIP亚单位疫苗有望作为奶牛无乳链球菌乳腺炎的候选亚单位疫苗。 相似文献
8.
《中国预防兽医学报》2020,(4)
为构建表面展示副结核分枝杆菌抗原MAP3007的大肠杆菌活载体疫苗株,本研究将冰核蛋白(INP)作为展示平台,将目的基因克隆于构建的pET-INP表面展示载体中,转入大肠杆菌BL21(DE3),经IPTG诱导表达后,对目的蛋白的表达与定位进行检测。将110只雌性BALB/c小鼠随机分为PBS组(30只),INP-28a对照组(30只),INP-MAP3007重组菌免疫组(30只),空白未攻毒组(20只),其中对照组INP-28a与重组菌INP-MAP3007免疫组以5×10~5cfu/200μL/只剂量分别免疫INP-28a空菌与INP-MAP3007重组疫苗,PBS组注射等体积PBS,3免后以5×10~8cfu/只进行副结核分支杆菌K-10株攻毒试验,空白未攻毒组不做处理,通过检测各组小鼠抗体水平、细胞因子、CD4~+和CD8~+T细胞亚群、增重率以及肠、肝脏和脾脏的病理损伤综合评价疫苗的免疫效果。结果显示,目的蛋白MAP3007正确表达且定位于细菌表面;经3次免疫后疫苗组与其他对照组相比能产生较高的抗体水平(p0.001);攻毒后与其他对照组相比,疫苗组小鼠细胞因子IFN-γ和IL-4极显著升高(p0.001),同时抗炎性细胞因子IL-10降低;疫苗组CD4~+T、CD8~+T淋巴细胞数量极显著增加(p0.001),且疫苗组小鼠体重增长速度与未攻毒组基本一致;病理组织学结果发现疫苗组各器官病变情况相对较轻或无显著病变。上述结果表明表面展示活载体疫苗能够诱导小鼠产生细胞免疫和体液免疫进而提供较好的免疫保护,且可以降低其病理损伤程度,减缓病程。本研究为新型副结核杆菌疫苗的研制奠定了基础。 相似文献
9.
【目的】 筛选猪链球菌血清3型疫苗候选菌株,制备猪链球菌3＋9型二价灭活疫苗并评估其在BALB/c小鼠上的免疫保护效果。【方法】 从发病猪病料中分离猪链球菌血清3型菌株,通过蜡螟幼虫和BALB/c小鼠模型筛选出强毒株作为疫苗候选菌株,并对候选菌株进行生物学特性研究。将筛选得到的3型疫苗候选菌株和前期筛选的9型疫苗候选菌株灭活浓缩,使其抗原浓度为2×1010 CFU/mL,无菌检测后将浓缩抗原液按1：1配比混合,再混合抗原与Summit Poly Solution佐剂按4：1比例混合,制备猪链球菌3＋9型二价灭活疫苗,疫苗中猪链球菌血清3和9型含菌量均为2×109 CFU/mL。将制备的疫苗免疫6周龄BALB/c小鼠,首免后第14天进行二免,二免后第14天进行攻毒。同时设立商品化疫苗免疫组和阴性对照组,评估疫苗的安全性和免疫保护效果。【结果】 PCR鉴定结果显示,23株临床分离株均为血清3型猪链球菌,依次命名为KQ3-1~KQ3-23。分别通过蜡螟和小鼠进行初筛和复筛,筛选到强毒株KQ3-1。毒力基因检测显示,该菌株基因型为gapdh＋/sly＋/fbps-/orf2-/mrp-/89K-/gdh＋/epf-;生长曲线显示,该菌株在37 ℃培养8~10 h时生长达到对数生长后期;BALB/c小鼠致病性结果显示,腹腔接种12 h内可引起小鼠精神萎靡、扎堆、毛发耸立、运动迟缓、死亡等临床症状,该菌株的LD50为5.2×107 CFU/只。制备的疫苗免疫小鼠后,小鼠精神状况、采食等均正常,疫苗注射部位无肿胀、硬块等不良反应,无死亡发生,表明该疫苗具有良好的安全性。免疫后进行猪链球菌血清2型菌株ZYS、猪链球菌血清3型菌株KQ3-1和猪链球菌血清9型菌株YT攻毒,对照组死亡率分别为90%、100%和100%,猪链球菌3＋9型二价灭活疫苗免疫组保护率分别为30%、80%和70%,商品化疫苗组的保护效果分别为70%、0和10%。【结论】 本研究研制的疫苗能对猪链球菌血清3和9型强毒株提供良好的免疫保护,该疫苗具备疫苗市场开发的潜在价值。 相似文献
10.
以限制性内切酶Sau3A I酶切禽多杀性巴氏杆菌基因组DNA,回收500～3 000 bp的DNA片段,连接真核表达裁体pcDNA3.1(+),电转化于大肠杆菌感受态细胞TG1中,构建禽多杀性巴氏杆菌的基因组表达文库.将文库随机分为5个子文库(子文库Ⅰ-子文库Ⅴ),分别提取各子文库重组质粒,以pcDNA3.1(+)和PBS为对照进行动物试验,每组16只BALB/c小鼠,各子文库组和pcDNA3.1(+)组以100 μg/只的剂量肌注免疫,PBS组每只小鼠肌注100μL 1×PBS,各组均免疫3次,每次间隔2周.间接ELISA检测免疫小鼠的血清抗体水平,MTT法检测免疫小鼠脾淋巴细胞增殖情况,三免2周后检测脾淋巴细胞IFN-γ的分泌情况.强毒攻击,计算小鼠的相对保护率.结果显示,动物免疫后子文库Ⅰ组质粒免疫的小鼠血清抗体水平及淋巴细胞增殖水平和IFN-γ分泌水平均持续上升,明显高于其他各组(P＜0.05).动物攻毒试验表明,各子文库组的重组质粒均可为免疫小鼠提供一定的保护,其中第Ⅰ组的保护效果最好,说明子文库Ⅰ组中含有较好的保护性抗原基因,这为进一步筛选相关的免疫原基因和研制新型疫苗奠定了的基础. 相似文献
11.
本试验旨在研究复合益生菌对肉鸽生长性能和免疫机能的影响。选取72对种鸽和144只1日龄乳鸽,乳鸽称量初始体重后随机分成4个试验组,每个试验组6个重复,每个重复3对种鸽及6只乳鸽。各组饲喂相同基础日粮,对照组补饲保健砂,Ⅰ组补饲保健砂+复合菌Ⅰ（6×107 CFU/g嗜酸乳杆菌+6×107 CFU/g乳双歧杆菌）,Ⅱ组补饲保健砂+复合菌Ⅱ（6×107 CFU/g乳双歧杆菌+6×107 CFU/g粪肠球菌）,Ⅲ组补饲保健砂+复合菌Ⅲ（6×107 CFU/g嗜酸乳杆菌+6×107 CFU/g粪肠球菌）。试验期56 d。结果显示,与对照组相比,Ⅱ组显著提高了肉鸽的28和56日龄体重和平均日增重（P<0.05）。Ⅱ组显著提高了28日龄肉鸽的胸腺指数（P<0.05）;Ⅲ组显著提高了56日龄肉鸽的脾脏指数（P<0.05）。3个复合菌组提高了28和56日龄肉鸽血清中免疫球蛋白的含量,但均未达到显著水平（P>0.05）。综上所述,保健砂中添加复合益生菌可提高肉鸽的生长性能、免疫器官指数,并一定程度上能提高肉鸽的免疫力,其中乳双歧杆菌和粪肠球菌组效果最好。 相似文献
12.
L B Tabatabai G W Pugh M G Stevens M Phillips T J McDonald 《American journal of veterinary research》1992,53(10):1900-1907
A study was conducted to determine the effect of monophosphoryl lipid A (MPL) and trehalose dimycolate (TDM) as adjuvants on the protective responses in BALB/c mice vaccinated with Brucella abortus salt-extractable protein (BCSP) or proteinase-K-treated B abortus lipopolysaccharide (PKLPS). Mice were vaccinated with different doses of BCSP or PKLPS given alone or in combination with MPL or TDM. Mice were challenge-exposed 4 weeks later with virulent B abortus strain 2308. Two weeks after challenge exposure, the number of B abortus colony-forming units (CFU) per spleen, spleen weights, and spleen cell interleukin 1 production were measured. Serum IgG and IgM concentrations specific for vaccinal immunogens were measured before and after challenge exposure with B abortus. Spleen weights and mean B abortus CFU per vaccine group were significantly lower in BCSP- and PKLPS-vaccinated mice, compared with those of nonvaccinated control mice. Monophosphoryl lipid A enhanced the suppression of splenic infection when given with the BCSP vaccine, but not when given with the PKLPS vaccine. Trehalose dimycolate had no effect on mean CFU when given with BCSP, but incorporation of TDM resulted in a significant increase in mean CFU when given with PKLPS. Spleen weights in BCSP- or PKLPS-vaccinated mice were not different when these vaccines were combined with MPL or TDM. Because of the wide variation in the results, we could not conclude that vaccination with BCSP or PKLPS alone, or in combination with MPL altered spleen cell interleukin-1 production in B abortus-infected mice.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
13.
试验旨在构建表达猪附红细胞体ENO基因的质粒DNA,并测定其免疫效果。将猪附红细胞体ENO基因克隆到PVAX1真核表达载体上,然后转染到Vero细胞中进行表达并测定其免疫效果。将18只BALB/c小鼠（雌雄各半）随机分为3组（PVAX1-ENO质粒DNA免疫组、PVAX1空载体对照组及PBS对照组）,每组6只,每组小鼠对应免疫接种PVAX1-ENO质粒DNA、PVAX1空质粒和PBS。分离血清并通过ELISA方法测定血清中ENO蛋白抗体效价、IgG1和IgG2a抗体水平及IFN-γ和IL-4细胞因子水平。三免2周后每组选取3只小鼠检测CD4+和CD8+含量。结果显示,本试验成功构建了PVAX1-ENO质粒DNA,经PCR和酶切鉴定正确,并能在Vero细胞中成功表达。PVAX1-ENO质粒DNA免疫组ENO蛋白抗体水平、IgG1和IgG2a抗体水平、IFN-γ和IL-4细胞因子水平及CD4+和CD8+含量均显著高于PVAX1空载体对照组及PBS对照组（P<0.05）。结果表明,PVAX1-ENO质粒DNA可显著提高BALB/c小鼠的体液免疫水平,并在一定程度上刺激BALB/c小鼠细胞免疫。 相似文献
14.
Duration of strain 2308 infection and immunogenicity of Brucella abortus lipopolysaccharide in five strains of mice 总被引：2，自引：0，他引：2
A study was conducted to compare immunogenicity of a Brucella abortus lipopolysaccharide (LPS) and the duration of infection in 5 strains of mice. Mice of strains CBA/NJ, BALB/c, CD-1, C3H/HeN, and C3H/HeJ were allotted into 2 large groups (vaccinated with proteinase K-treated LPS or nonvaccinated) and 6 subgroups based on the intervals between challenge exposure to B abortus strain 2308 and the week the response data were obtained. Criteria used in comparing responses between the various strains of mice as well as between vaccinated and nonvaccinated mice were splenomegaly, colony-forming units (CFU) from spleens, and antibody titers. Responses were evaluated at 1, 2, 3, 5, 8, and 12 weeks after challenge exposure. Results indicated that all strains of mice became infected and maintained infection throughout the 12-week period, the percentages of mice infected were significantly (P less than 0.05) less in vaccinated mice for the first 5 weeks after challenge exposure, and there were no direct correlations between increased immunoglobulins (IgM and IgG titers) and reduction in CFU. Vaccinated mice of strains BALB/c, CD-1, C3H/HeN, and C3H/HeJ had increased titers when challenge exposed and also had significantly (P less than 0.05) smaller spleens and lower CFU. Vaccinated CBA/NJ mice did not have marked antibody titers. The overall results indicated that vaccination with LPS offers some initial protection against B abortus strain 2308 infection, but this protection disappears gradually and in various degrees in the 5 strains of mice studied. 相似文献
15.
This experiment was conducted to investigate the effects of different compound probiotics on growth performance and immune function of pigeons. 72 pairs of breeding pigeons and 144 squabs were selected and randomly divided into 4 groups with 6 replicates per group and 3 pairs of breeding pigeons and 6 young pigeons per replicate.The pigeons in all groups were fed the basal diet with health care sand,meanwhile and pigeons in groups Ⅰ, Ⅱ and Ⅲ supplemented with compound probiotics Ⅰ (6×107 CFU/g Lactobacillus acidophilus+6×107 CFU/g Bifidobacterium lactis),compound probiotics Ⅱ (6×107 CFU/g Bifidobacterium lactis+6×107 CFU/g Enterococcus faecalis) and compound probiotics Ⅲ (6×107 CFU/g Lactobacillus acidophilus+6×107 CFU/g Enterococcus faecalis),resperctively. The experiment lasted for 56 d. The results showed that compared with the control group,compound probiotics Ⅱ could significantly increase the body weight and the average daily gain of pigeon at 28 and 56 days of age (P<0.05). The thymus index of the 28 days old pigeon in group Ⅱ was significantly increased (P<0.05),and the spleen index of the 56 days old pigeon in group Ⅲ was significantly increased (P<0.05). All the compound probiotics groups could increase serum immunoglobulin content of 28 and 56 days old pigeon,but did not reach a significant level (P>0.05).In summary,compound probiotics could improve the growth performance and immune organ indexes,and improve the immunity of pigeon to a certain extent, the Bifidobacterium lactis and Enterococcus feacalis had the better effect. 相似文献
16.
V S Panangala T B Haynes R D Schultz A Mitra 《Veterinary immunology and immunopathology》1986,13(1-2):71-84
Immunomodulation with killed Propionibacterium acnes was attempted in guinea pigs simultaneously vaccinated with Brucella abortus strain 19. Two groups, each comprised of 9 guinea pigs, were injected by different routes (s.c. and or i.v.) with 1.4 mg of P. acnes and 5 X 10(8) CFU of B. abortus, S-19, while 3 other groups each received either P. acnes, B. abortus S-19, or saline (s.c.). The antibody titers to B. abortus measured at 6, 10 and 14 weeks after vaccination indicated no significant (P less than 0.01) response in the 2 groups immunopotentiated with P. acnes concurrent with B. abortus S-19 vaccination. The delayed hypersensitivity response to 3 Brucella antigens conducted 8 weeks after immunization did not show a significant difference between the B. abortus S-19 vaccinated group compared with the 2 groups immunopotentiated and vaccinated. However, the proliferative response of lymphocytes to the B. abortus soluble antigen diluted 1:100 indicated significantly enhanced blastogenesis in the (s.c.) immunopotentiated and immunized guinea pigs compared with the B. abortus S-19 vaccinated group. A slightly enhanced response was also observed in the group immunopotentiated (i.v.) and vaccinated (s.c.). The guinea pigs were challenged with B. abortus strain 2308 and necropsied 4 weeks later. The mean splenic CFU of the Brucella in the group immunopotentiated (i.v.) and vaccinated (s.c.) was significantly decreased when compared with the guinea pigs vaccinated with B. abortus S-19 alone. These findings indicated that P. acnes administered simultaneously with B. abortus S-19 vaccine was able to augment the immune response in guinea pigs. Immunomodulation as evidenced by enhanced clearance of B. abortus from the spleens of immunopotentiated animals was presumably brought about by activated macrophages or a T-cell mediated cytolytic mechanism or both. 相似文献
17.
单核细胞增生性李斯特菌(Listeria monocytogenes,LM)是一种人畜共患食源性致病菌,能引起人和动物较为严重的感染症状。现广泛使用具有免疫活性的小鼠模型测定半数致死量(LD50)来评价不同LM菌株的致病性。为建立LM的ICR小鼠模型,本研究采用1/2a血清型的N21 LM菌株,分别以106、107、108、109和1010 CFU的剂量口腔灌注感染6周龄ICR小鼠,每组10只;另取10只接种PBS作为对照组,测定LM对ICR小鼠的LD50;另取40只小鼠,平均分为2组,公母各半,以测定的LD50剂量接种LM,分别对各组小鼠临床症状、组织病理变化、体重变化及组织中细菌载量进行评价。结果发现,N21 LM菌株对ICR小鼠的LD50为109.25 CFU;感染周期为10 d左右,感染小鼠出现被毛粗糙、精神萎靡、阴茎垂出及体重下降等临床症状。组织病理学分析结果显示,肝脏先后出现实质内灶状细菌团块、形成血栓、细胞坏死等;脾脏主要表现为白髓内淋巴细胞减少;肺脏主要表现为纤维素性肺炎。菌落计数和Real-time PCR的检测结果发现肝脏中细菌载量最高,脾脏次之。结果表明,ICR小鼠能作为单核细胞增生性李斯特菌的感染模型。本试验结果为研究LM的致病机制、疫苗研究及抗菌肽转基因小鼠抗LM的评价奠定了基础。 相似文献
18.
To characterize the optimal aerosol dosage of Brucella abortus strain 2308 (S2308) and B. melitensis (S16M) in a laboratory animal model of brucellosis, dosages of 10(3)-10(10) colony forming units (CFU) were nebulized to mice. Although tissue weights were minimally influenced, total CFU per tissues increased beginning at 10(6)-10(7) CFU dosages, with 10(9) CFU appearing to be an optimal dosage for S16M or S2308 aerosol delivery. At 12 weeks after vaccination with 10(7) CFU of B. abortus strain RB51 (SRB51) or saline (control), mice were challenged intraperitoneally (i.p.) (6.4 x 10(4) CFU) or via aerosol (1.76 x 10(9) CFU) with S2308. Mice vaccinated with SRB51 had reduced (P < 0.05) splenic, liver and lung colonization (total CFU and CFU/g) after i.p. challenge with S2308 as compared with control mice after i.p. S2308 challenge. Control and SRB51-vaccinated mice did not differ (P > 0.05) in splenic, liver or lung colonization after aerosol S2308 challenge. Failure to demonstrate vaccine protection was not because of a high aerosol challenge dosage as colonization of spleen and liver tissues was lower (P < 0.05) after aerosol challenge when compared with control mice after i.p. S2308 challenge. 相似文献
19.
Brucella species lacking the major outer membrane protein Omp25 are attenuated in mice and protect against Brucella melitensis and Brucella ovis 总被引：7，自引：0，他引：7
To aid in the development of novel efficacious vaccines against brucellosis, Omp25 was examined as a potential candidate. To determine the role of Omp25 in virulence, mutants were created with Brucella abortus (BA25), Brucella melitensis (BM25), and Brucella ovis (BO25) which contain disruptions in the omp25 gene (Deltaomp25 mutants). Western immunoblot analysis and PCR verified that the Omp25 protein was not expressed and that the omp25 gene was disrupted in each strain. BALB/c mice infected with B. abortus BA25 or B. melitensis BM25 showed a significant decrease in mean CFU/spleen at 18 and 4 weeks post-infection, respectively, when compared to the virulent parental strain (P<0.05, n=5). Mice infected with B. ovis BO25 had significantly lower mean CFU/spleen counts from 1 to 8 weeks post-infection, at which point the mutant was cleared from the spleens (P<0.01, n=5). Murine vaccination with either BM25 or the current caprine vaccine B. melitensis strain Rev. 1 resulted in more than a 2log(10) reduction in bacterial load following challenge with virulent B. melitensis (P<0.01, n=5). Vaccination of mice with the B. ovis mutant resulted in clearance of the challenge strain and provided 2.5log(10) greater protection against virulent B. ovis than vaccine strain Rev. 1. Based on these data, the B. melitensis and B. ovis Deltaomp25 mutants are interesting vaccine candidates that are currently under study in our laboratory for their safety and efficacy in small ruminants. 相似文献
20.
WANG Yan CHEN Nan-nan HOU Mei-ru YIN Jun-yi LIU Yu ZHOU Qing-min QIN Ping-wei SHI Tong-rui 《中国畜牧兽医》2017,44(3):928-934
In order to determine the safety of Bacillus amyloliquefaciens SSY1, we carried out the acute toxicity, chronic toxicity, bacterial translocation, product of metabolism and drug susceptibility test. Acute toxicity test in high dose groups (1.30×1010 CFU/mL), middle dose group(0.90×1010 CFU/mL), low dose group (0.65×1010 CFU/mL) and normal saline control group. After the acute toxicity test, the mice were sacrificed 14 days after the observation. Chronic toxicity test of each group was administered once a day for 30 d, chronic toxicity test in high dose groups (0.65×1010 CFU/mL), middle dose group (0.65×109 CFU/mL), low dose group (0.65×108 CFU/mL) and normal saline control group. The results showed that all mice were without exception phenomenon, the spirit, appetite, behavior and feces and so on, no pathological changes were found on the acute toxicity test. Chronic toxicity test of the mice were no abnormal clinical changes, and there were no pathological changes. Body weight and feed utilization rate of mice, hematology, blood biochemistry indexes and viscera coefficient difference were not significant (P>0.05);Bacillus amyloliquefaciens SSY1 strain did not occur translocation in mice, amino acid decarboxylase and indole test were negative, among the 24 kinds of commonly used drugs, the strains were sensitive to 23 kinds of drugs except the cillimycin. This experiment proved that Bacillus amyloliquefaciens SSY1 had good security. 相似文献